Angel Broking is bullish on Sun Pharma and has recommended buy rating on the stock with a target of Rs 950 in its November 17, 2015 research report.

Hold Sun Pharma ;target of Rs 825:ICICI Direct

ICICI Direct has recommended hold rating on Sun Pharma with a target price of Rs 825 in its research report dated November 6, 2015.

Accumulate Sun Pharma; target of Rs 910: KRChoksey

KRChoksey is bullish on Sun Pharmaceutical Industries and has recommended accumulate rating on the stock with a target price of Rs 910 in its research report dated August 12, 2015.

Accumulate Sun Pharma; target of Rs 910: KRChoksey

KRChoksey is bullish on Sun Pharmaceutical Industries and has recommended accumulate rating on the stock with a target price of Rs 910 in its research report dated August 12, 2015.

Hold Sun Pharma; target of Rs 850: ICICIdirect

ICICIdirect.com has recommended to hold Sun Pharmaceutical Industries with a target price of Rs 850, in its research report dated July 21, 2015.

Buy Sun Pharma; target of Rs 1015: Angel Broking

Angel Broking is bullish on Sun Pharmaceutical Industries and has recommended buy rating on the stock with a target of Rs 1015 in its research report dated June 11, 2015.

Accumulate Sun Pharma; target Rs 1026: Kotak Securities

Kotak Securities is bullish on Sun Pharmaceutical Industries and has recommended accumulate rating on the stock with a target price of Rs 1026, in its research report dated February 16, 2015.

Accumulate Sun Pharma; target of Rs 991: KRChoksey

KRChoksey is bullish on Sun Pharmaceutical Industries and has recommended accumulate rating on the stock with a target price of Rs 991 in its research report dated February 16, 2015.

Long Sun Pharma; short Lupin: Emkay

Emkay Global Financial Services has recommended to buy Sun Pharma at Rs 806-808 and sell Lupin at Rs 1422-1424 in anticipation of a reversion in the price ratio, in its research report dated December 22, 2014.

Angel Broking neutral on Sun Pharmaceutical Industries

Angel Broking has maintained a neutral rating on Sun Pharmaceutical Industries, in its November 14, 2014 research report.

Hold Sun Pharma; target of Rs 915: KRChoksey

Brokerage house KRChoksey has recommended a hold rating on Sun Pharmaceutical Industries with a target price of Rs 915 per share in its November 14, 2014 research report.

Buy Sun Pharma; target of Rs 1033: Achiievers

Achiievers is bullish on Sun Pharmaceutical Industries and has recommended buy rating on the stock with a target of Rs 1033 in its October 1, 2014 research report.

Buy Sun Pharma; target of Rs 944: Firstcall Research

Firstcall Research is bullish on Sun Pharmaceutical Industries and has recommended buy rating on the stock with a target of Rs 944 in its September 06, 2014 research report.

Buy Sun Pharma; target of Rs 980: Motilal Oswal

Motilal Oswal is bullish on Sun Pharmaceutical and has recommended buy rating on the stock with a target of Rs 980 in its September 3, 2014 research report.

Buy Sun Pharma; target of Rs 928: Emkay

Brokerage house Emkay Global Financial Services is bullish on Sun Pharmaceutical Industries and has recommended buy rating on the stock with a target price of Rs 928 in its August 13, 2014 research report.

Hold Sun Pharma; target of Rs 800: KRChoksey

Brokerage house KRChoksey has recommended a hold rating on Sun Pharmaceutical Industries with a target price of Rs 800 per share in its August 13, 2014 research report.

Angel Broking neutral on Sun Pharma

Angel Broking has maintained a 'Neutral' rating on Sun Pharmaceutical Industries, in its August 14, 2014 research report.

Buy Sun Pharma; target of Rs 706: Angel Broking

Brokerage house Angel Broking is bullish on Sun Pharmaceutical Industries and has recommended 'Buy' rating on the stock with a target price of Rs 706 in its research report dated June 02, 2014.

Buy Sun Pharma; target of Rs 661: Angel Broking

Brokerage house Angel Broking is bullish on Sun Pharmaceutical Industries and has recommended 'Buy' rating on the stock with a target price of Rs 661 in its research report dated April 07, 2014.

Accumulate Sun Pharma; target of Rs 703: Dolat Capital

Dolat Capital is bullish on Sun Pharmaceutical Industries and has recommended 'Accumulate' rating on the stock with a target price of Rs 703 in its February 13, 2014 research report.

Buy Sun Pharma, Tata Coffee: Systematix Shares

Systematix Shares is bullish on Sun Pharmaceutical Industries, Tata Coffee and has recommended to buy both the stocks for target price of Rs 619 and Rs 1059 respectively, in its research report dated January 09, 2014.

Buy Sun Pharma; target of Rs 718: Motilal Oswal

Brokerage house Motilal Oswal is bullish on Sun Pharmaceutical Industries and has recommended buy rating on the stock with a target price of Rs 718, in its research report November 2013.

Buy Sun Pharma; target Rs 670: Firstcall Research

Brokerage house Firstcall Research is bullish on Sun Pharmaceutical Industries and has recommended buy rating on the stock with a target price of Rs 670 in its November 19, 2013 research report.

Accumulate Sun Pharma; target Rs 664: Dolat Capital

Dolat Capital is bullish on Sun Pharmaceutical Industries and has recommended 'Accumulate' rating on the stock with a target price of Rs 664 in its November 14, 2013 research report.

Buy Sun Pharma; target of Rs 600: Motilal Oswal

Motilal Oswal is bullish on Sun Pharma and has recommended buy rating on the stock with a target of Rs 600 in its September 12, 2013 research report.